Profile data is unavailable for this security.
About the company
Shanghai Fudan Forward S&T Co Ltd is a China-based company mainly engaged in the research and development, production and sales of drugs. The Company mainly operates three businesses, including pharmaceuticals, software and park business. The pharmaceutical business is engaged in the research and development, production and sales of digestive system drugs, nervous system drugs, anti-tumor drugs, circulatory system drugs and immune function regulation drugs. The software business mainly provides financial insurance system software products. The park business includes self-owned housing leasing, real estate development and operation, investment promotion, consulting services, property management and supporting services. The Company mainly conducts businesses within the domestic market.
- Revenue in CNY (TTM)661.28m
- Net income in CNY-119.02m
- Incorporated1990
- Employees1.41k
- LocationShanghai Fudan Forward S&T Co LtdNo. 525, Guoquan RoadSHANGHAI 200433ChinaCHN
- Phone+86 2 163872288
- Fax+86 2 163869700
- Websitehttps://www.forwardgroup.com
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lionco Pharmaceutical Group Co Ltd | 430.61m | -118.38m | 3.45bn | 436.00 | -- | 4.69 | -- | 8.01 | -0.1609 | -0.1609 | 0.5928 | 1.02 | 0.3578 | 3.93 | 2.41 | 987,638.40 | -9.84 | -2.45 | -11.09 | -3.13 | 45.89 | 72.39 | -27.49 | -9.67 | 2.80 | -2.73 | 0.2791 | -- | 92.95 | -25.32 | 13.68 | -- | -4.03 | -- |
| Shanghai Hile Bio-Technology Co Ltd | 246.35m | 171.34m | 3.52bn | 366.00 | 18.01 | 2.31 | -- | 14.29 | 0.2998 | 0.2998 | 0.3895 | 2.34 | 0.1438 | 0.8346 | 2.49 | 673,097.90 | 11.90 | 4.15 | 14.28 | 5.65 | 75.26 | 52.88 | 82.75 | 25.09 | 6.92 | -- | 0.0106 | 26.17 | 12.59 | -0.5053 | 172.28 | 69.73 | -26.47 | 67.20 |
| Shanghai Fudan Forward S&T Co Ltd | 661.28m | -119.02m | 3.63bn | 1.41k | -- | 5.83 | -- | 5.49 | -0.1744 | -0.1744 | 0.9721 | 0.9158 | 0.4268 | 0.8015 | 9.29 | 467,663.00 | -7.83 | -3.33 | -14.36 | -5.82 | 32.05 | 39.99 | -18.35 | -7.67 | 0.4787 | -12.63 | 0.4378 | -- | -5.05 | -14.35 | -509.42 | -- | -18.59 | -- |
| Beijing Kawin Technol Sha-hld Co Ltd | 1.15bn | 136.81m | 3.78bn | 600.00 | 28.03 | 2.06 | -- | 3.30 | 0.789 | 0.789 | 6.61 | 10.73 | 0.4166 | 1.52 | 2.64 | 1,910,937.00 | 5.26 | 5.55 | 7.12 | 7.14 | 81.89 | 84.98 | 12.64 | 9.40 | 2.55 | -- | 0.2017 | 45.97 | -12.87 | 8.32 | 22.18 | 21.60 | 40.30 | -- |
| Zhejiang Cheng Yi Pharmaceutical Co Ltd | 790.86m | 226.35m | 3.81bn | 738.00 | 16.62 | 2.88 | -- | 4.81 | 0.6997 | 0.6997 | 2.46 | 4.04 | 0.4508 | 1.95 | 20.88 | -- | 13.02 | 11.48 | 15.87 | 14.03 | 68.99 | 69.02 | 28.88 | 24.63 | 0.985 | -- | 0.0808 | 37.22 | 6.36 | 0.9546 | 23.21 | 8.84 | -20.09 | 11.39 |
| Henan Taloph Pharmaceutical Stock Co Ltd | 1.79bn | 46.95m | 3.88bn | 2.21k | 76.49 | 2.44 | -- | 2.17 | 0.0884 | 0.0884 | 3.31 | 2.78 | 0.4791 | 2.74 | 1.60 | 807,429.60 | 1.45 | 0.3241 | 3.13 | 0.6105 | 23.45 | 26.22 | 3.02 | 0.6331 | 0.9038 | 1.86 | 0.3592 | 52.82 | -6.21 | 8.16 | 16.00 | 2.61 | -19.14 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2025 | 321.70k | 0.05% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 52.90k | 0.01% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 14.50k | 0.00% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2025 | 3.60k | 0.00% |
| Guotai Asset Management Co., Ltd.as of 30 Jun 2025 | 1.00k | 0.00% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 0.00 | 0.00% |
